Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $499.00 | 7 | 92.6% |
| Education | $39.99 | 1 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $319.04 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $70.09 | 1 | $0 (2017) |
| Amgen Inc. | $67.05 | 1 | $0 (2018) |
| PFIZER INC. | $39.99 | 1 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $29.87 | 1 | $0 (2020) |
| Siemens Medical Solutions USA, Inc. | $12.95 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.99 | 1 | PFIZER INC. ($39.99) |
| 2020 | $29.87 | 1 | Bard Peripheral Vascular, Inc. ($29.87) |
| 2019 | $12.95 | 1 | Siemens Medical Solutions USA, Inc. ($12.95) |
| 2018 | $261.09 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($194.04) |
| 2017 | $195.09 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($125.00) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $39.99 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 03/26/2019 | Siemens Medical Solutions USA, Inc. | syngo.via (Device) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: SY - Image and Knowledge Management | ||||||
| 10/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $81.50 | General |
| 07/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $112.54 | General |
| 05/23/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $67.05 | General |
| Category: Endocrinology | ||||||
| 08/17/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $70.09 | General |
| Category: Oncology | ||||||
| 03/22/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 6,968 | 7,170 | $531,713 | $169,010 |
| 2022 | 72 | 12,228 | 12,945 | $853,708 | $266,658 |
| 2021 | 64 | 8,953 | 9,235 | $729,575 | $231,076 |
| 2020 | 62 | 6,526 | 6,761 | $573,245 | $178,376 |
All Medicare Procedures & Services
252 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 1,257 | 1,257 | $66,218 | $45,696 | 69.0% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 1,177 | 1,177 | $101,278 | $34,038 | 33.6% |
| 77067 | Screening mammography | Office | 2023 | 272 | 272 | $30,736 | $9,914 | 32.3% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 257 | 257 | $23,130 | $7,461 | 32.3% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 329 | 338 | $29,068 | $6,550 | 22.5% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 208 | 227 | $14,528 | $5,963 | 41.0% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 163 | 164 | $12,792 | $5,341 | 41.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 460 | 460 | $21,416 | $4,347 | 20.3% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 480 | 499 | $17,450 | $3,647 | 20.9% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 487 | 575 | $16,674 | $3,644 | 21.9% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 41 | 41 | $13,366 | $3,509 | 26.3% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 146 | 146 | $13,140 | $3,379 | 25.7% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 131 | 140 | $15,960 | $3,222 | 20.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 49 | 49 | $14,063 | $3,030 | 21.5% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 93 | 98 | $11,662 | $3,015 | 25.9% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 79 | 79 | $11,534 | $2,892 | 25.1% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 20 | 20 | $10,780 | $2,340 | 21.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 29 | 29 | $7,946 | $1,934 | 24.3% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 67 | 68 | $9,860 | $1,808 | 18.3% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 63 | 64 | $6,834 | $1,733 | 25.4% |
| 77049 | Mri scan of both breasts | Office | 2023 | 20 | 20 | $23,000 | $1,699 | 7.4% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 35 | 35 | $6,405 | $1,223 | 19.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 110 | 110 | $3,300 | $1,040 | 31.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 36 | 36 | $4,212 | $997.11 | 23.7% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 21 | 21 | $4,200 | $888.34 | 21.2% |
About Dr. Christopher Levey, M.D
Dr. Christopher Levey, M.D is a Diagnostic Radiology healthcare provider based in Easton, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841200672.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Levey, M.D has received a total of $538.99 in payments from pharmaceutical and medical device companies, with $39.99 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($499.00).
As a Medicare-enrolled provider, Levey has provided services to 34,675 Medicare beneficiaries, totaling 36,111 services with total Medicare billing of $845,120. Data is available for 4 years (2020–2023), covering 252 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Easton, MD
- Active Since 08/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1841200672
Products in Payments
- TAGRISSO (Drug) $70.09
- Prolia (Biological) $67.05
- XTANDI (Drug) $39.99
- syngo.via (Device) $12.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Easton
Brandon Shearer, D.o, D.O
Diagnostic Radiology — Payments: $8,787
Ali Jon, Md, MD
Diagnostic Radiology — Payments: $3,065
Dr. Simon Roh, M.d, M.D
Diagnostic Radiology — Payments: $2,943
Dr. Andrew Heckman, M.d, M.D
Diagnostic Radiology — Payments: $2,568
Dr. Robert Reinhart, Md, MD
Diagnostic Radiology — Payments: $2,471
David Ball, Do, DO
Diagnostic Radiology — Payments: $961.08